Two Sigma Advisers’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $826K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $604K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $1.3M | Sell |
|
|||||
|
2022
Q4 | $2.97M | Sell |
|
|||||
|
2022
Q3 | $3.38M | Sell |
|
|||||
|
2022
Q2 | $6.2M | Buy |
|
|||||
|
2022
Q1 | $5.25M | Buy |
|
|||||
|
2021
Q4 | $2.33M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $2.93M | Sell |
|
|||||
|
2021
Q1 | $4.33M | Sell |
|
|||||
|
2020
Q4 | $7.04M | Sell |
|
|||||
|
2020
Q3 | $6.58M | Buy |
|
|||||
|
2020
Q2 | $729K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $37K | Sell |
|
|||||
|
2019
Q3 | $43K | Sell |
|
|||||
|
2019
Q2 | $72K | Sell |
|
|||||
|
2019
Q1 | $147K | Sell |
|
|||||
|
2018
Q4 | $126K | Sell |
|
|||||
|
2018
Q3 | $288K | Buy |
|
|||||
|
2018
Q2 | $151K | Buy |
|
|||||
|
2018
Q1 | $72K | Sell |
|
|||||
|
2017
Q4 | $238K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $189K | Buy |
|